Cargando…
A pharmacokinetic evaluation and metabolite identification of the GHB receptor antagonist NCS‐382 in mouse informs novel therapeutic strategies for the treatment of GHB intoxication
Gamma‐aminobutyric acid (GABA) is an endogenous inhibitory neurotransmitter and precursor of gamma‐hydroxybutyric acid (GHB). NCS‐382 (6,7,8,9‐tetrahydro‐5‐hydroxy‐5H‐benzo‐cyclohept‐6‐ylideneacetic acid), a known GHB receptor antagonist, has shown significant efficacy in a murine model of succinic...
Autores principales: | Ainslie, Garrett R., Gibson, K. Michael, Vogel, Kara R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5115179/ https://www.ncbi.nlm.nih.gov/pubmed/27891231 http://dx.doi.org/10.1002/prp2.265 |
Ejemplares similares
-
Understandings, attitudes, practices and responses to GHB overdose among GHB consumers
por: Freestone, Jack, et al.
Publicado: (2023) -
Effect of Repeated Administration of ɣ-Valerolactone (GVL) and GHB in the Mouse: Neuroadaptive Changes of the GHB and GABAergic System
por: Frisoni, Paolo, et al.
Publicado: (2023) -
Characterization of the GHB Withdrawal Syndrome
por: Wolf, Casper J. H., et al.
Publicado: (2021) -
Effect of GHB-use and GHB-induced comas on dorsolateral prefrontal cortex functioning in humans
por: Raposo Pereira, Filipa, et al.
Publicado: (2018) -
Effects of Recreational GHB Use and Multiple GHB-Induced Comas on Brain Structure and Impulsivity
por: Raposo Pereira, Filipa, et al.
Publicado: (2020)